Cognitive impairment among medicare home health patients: comparing available measures.
Julia G BurgdorfHalima AmjadPublished in: Home health care services quarterly (2021)
There is growing interest in understanding home health utilization and outcomes for those with cognitive impairment (CI). Yet, approaches to measuring CI during home health vary widely across studies, with little known regarding potential implications for findings. Among a nationally representative sample of community-living Medicare beneficiaries receiving home health (2011-2016), we compare estimated CI prevalence using four different measures and evaluate measure-specific strengths and limitations. CI prevalence estimates ranged from 18.4% of the sample with probable dementia from national survey data; to 27.8% with diagnosed dementia, from Medicare claims; to 26.7% with memory deficit and/or impaired decision-making and 43.9% with reduced cognitive function, from OASIS. Researchers must be deliberate in their choice of CI measure and transparent regarding its benefits and limitations. Regardless of the measure used, a sizable percentage of home health patients have CI, supporting the importance of ongoing research in this area.
Keyphrases
- healthcare
- cognitive impairment
- public health
- mental health
- end stage renal disease
- ejection fraction
- chronic kidney disease
- health information
- newly diagnosed
- mild cognitive impairment
- human health
- working memory
- peritoneal dialysis
- adipose tissue
- health insurance
- machine learning
- social media
- patient reported outcomes
- affordable care act
- big data
- electronic health record
- metabolic syndrome